TQB2930 Injection for the Treatment of HER2-positive Advanced Breast Cancer
Clinical trial NCT07047365 · RECRUITING
Trial details
- NCT number
- NCT07047365
- Sponsor
- Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-07-25
- Primary completion
- 2028-06-01
- Enrollment
- 416
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.